Weil, Gotshal & Manges Advises Pfizer in Agreement for Advanced Medical Optics to Acquire Pfizer's Surgical Ophthalmology Busine
April 23 2004 - 6:21PM
PR Newswire (US)
Weil, Gotshal & Manges Advises Pfizer in Agreement for Advanced
Medical Optics to Acquire Pfizer's Surgical Ophthalmology Business
NEW YORK, April 23 /PRNewswire/ -- Weil, Gotshal & Manges LLP,
one of the world's leading law firms, advised Pfizer Inc in its
definitive agreement with Advanced Medical Optics, Inc. (AMO) for
AMO to acquire Pfizer's surgical ophthalmology business for $450
million in cash. AMO is a global leader in the development,
manufacturing and marketing of ophthalmic surgical and contact lens
care products. Pfizer Inc is a research-based global
pharmaceuticals company that discovers, develops, manufactures, and
markets innovative medicines for humans and animals. Weil, Gotshal
& Manges LLP is an international law firm of more than 1,100
attorneys, including approximately 300 partners. Weil Gotshal is
headquartered in New York, with offices in Austin, Boston,
Brussels, Budapest, Dallas, Frankfurt, Houston, London, Miami,
Munich, Paris, Prague, Silicon Valley, Singapore, Warsaw and
Washington, D.C. Weil, Gotshal & Manges LLP's Team Partners:
Raymond O. Gietz (Corporate - New York); Stanley M. Spracker
(Environmental - Washington, DC) Associates: Stefan J. Wright,
Louis J. Gambino and Greg H. Stoller (Corporate - New York)
DATASOURCE: Weil, Gotshal & Manges LLP CONTACT: Les Zuke of
Weil, Gotshal & Manges LLP, +1-212-310-8410, or Terri Cohen of
Rubenstein Associates +1-212-843-8018, for Weil, Gotshal &
Manges LLP
Copyright
Advanced medical Optics (NYSE:AVO)
Historical Stock Chart
From Jun 2024 to Jul 2024
Advanced medical Optics (NYSE:AVO)
Historical Stock Chart
From Jul 2023 to Jul 2024